The Medical Radioisotopes market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Medical Radioisotopes size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Medical Radioisotopes market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Medical Radioisotopes market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Mo-99
Co-60
Lutetium 177
Market segment by Application, can be divided into
Nuclear Therapy
Equipment Radioactive Source
Diagnosis
Market segment by players, this report covers
NRG
NTP Radioisotopes
ANSTO
IRE
Nordion
Curium Pharma
Eckert & Ziegler Strahlen
Polatom
China National Nuclear Corporation
IDB Holland
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Medical Radioisotopes
1.2 Classification of Medical Radioisotopes by Type
1.2.1 Overview: Global Medical Radioisotopes Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Medical Radioisotopes Revenue Market Share by Type in 2020
1.2.3 Mo-99
1.2.4 Co-60
1.2.5 Lutetium 177
1.3 Global Medical Radioisotopes Market by Application
1.3.1 Overview: Global Medical Radioisotopes Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Nuclear Therapy
1.3.3 Equipment Radioactive Source
1.3.4 Diagnosis
1.4 Global Medical Radioisotopes Market Size & Forecast
1.5 Global Medical Radioisotopes Market Size and Forecast by Region
1.5.1 Global Medical Radioisotopes Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Medical Radioisotopes Market Size by Region, (2016-2021)
1.5.3 North America Medical Radioisotopes Market Size and Prospect (2016-2026)
1.5.4 Europe Medical Radioisotopes Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Medical Radioisotopes Market Size and Prospect (2016-2026)
1.5.6 South America Medical Radioisotopes Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Medical Radioisotopes Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Medical Radioisotopes Market Drivers
1.6.2 Medical Radioisotopes Market Restraints
1.6.3 Medical Radioisotopes Trends Analysis
2 Company Profiles
2.1 NRG
2.1.1 NRG Details
2.1.2 NRG Major Business
2.1.3 NRG Medical Radioisotopes Product and Solutions
2.1.4 NRG Medical Radioisotopes Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 NRG Recent Developments and Future Plans
2.2 NTP Radioisotopes
2.2.1 NTP Radioisotopes Details
2.2.2 NTP Radioisotopes Major Business
2.2.3 NTP Radioisotopes Medical Radioisotopes Product and Solutions
2.2.4 NTP Radioisotopes Medical Radioisotopes Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 NTP Radioisotopes Recent Developments and Future Plans
2.3 ANSTO
2.3.1 ANSTO Details
2.3.2 ANSTO Major Business
2.3.3 ANSTO Medical Radioisotopes Product and Solutions
2.3.4 ANSTO Medical Radioisotopes Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 ANSTO Recent Developments and Future Plans
2.4 IRE
2.4.1 IRE Details
2.4.2 IRE Major Business
2.4.3 IRE Medical Radioisotopes Product and Solutions
2.4.4 IRE Medical Radioisotopes Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 IRE Recent Developments and Future Plans
2.5 Nordion
2.5.1 Nordion Details
2.5.2 Nordion Major Business
2.5.3 Nordion Medical Radioisotopes Product and Solutions
2.5.4 Nordion Medical Radioisotopes Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Nordion Recent Developments and Future Plans
2.6 Curium Pharma
2.6.1 Curium Pharma Details
2.6.2 Curium Pharma Major Business
2.6.3 Curium Pharma Medical Radioisotopes Product and Solutions
2.6.4 Curium Pharma Medical Radioisotopes Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Curium Pharma Recent Developments and Future Plans
2.7 Eckert & Ziegler Strahlen
2.7.1 Eckert & Ziegler Strahlen Details
2.7.2 Eckert & Ziegler Strahlen Major Business
2.7.3 Eckert & Ziegler Strahlen Medical Radioisotopes Product and Solutions
2.7.4 Eckert & Ziegler Strahlen Medical Radioisotopes Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Eckert & Ziegler Strahlen Recent Developments and Future Plans
2.8 Polatom
2.8.1 Polatom Details
2.8.2 Polatom Major Business
2.8.3 Polatom Medical Radioisotopes Product and Solutions
2.8.4 Polatom Medical Radioisotopes Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Polatom Recent Developments and Future Plans
2.9 China National Nuclear Corporation
2.9.1 China National Nuclear Corporation Details
2.9.2 China National Nuclear Corporation Major Business
2.9.3 China National Nuclear Corporation Medical Radioisotopes Product and Solutions
2.9.4 China National Nuclear Corporation Medical Radioisotopes Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 China National Nuclear Corporation Recent Developments and Future Plans
2.10 IDB Holland
2.10.1 IDB Holland Details
2.10.2 IDB Holland Major Business
2.10.3 IDB Holland Medical Radioisotopes Product and Solutions
2.10.4 IDB Holland Medical Radioisotopes Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 IDB Holland Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Medical Radioisotopes Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Medical Radioisotopes Players Market Share
3.2.2 Top 10 Medical Radioisotopes Players Market Share
3.2.3 Market Competition Trend
3.3 Medical Radioisotopes Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Medical Radioisotopes Revenue and Market Share by Type (2016-2021)
4.2 Global Medical Radioisotopes Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Medical Radioisotopes Revenue Market Share by Application (2016-2021)
5.2 Medical Radioisotopes Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Medical Radioisotopes Revenue by Type (2016-2026)
6.2 North America Medical Radioisotopes Revenue by Application (2016-2026)
6.3 North America Medical Radioisotopes Market Size by Country
6.3.1 North America Medical Radioisotopes Revenue by Country (2016-2026)
6.3.2 United States Medical Radioisotopes Market Size and Forecast (2016-2026)
6.3.3 Canada Medical Radioisotopes Market Size and Forecast (2016-2026)
6.3.4 Mexico Medical Radioisotopes Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Medical Radioisotopes Revenue by Type (2016-2026)
7.2 Europe Medical Radioisotopes Revenue by Application (2016-2026)
7.3 Europe Medical Radioisotopes Market Size by Country
7.3.1 Europe Medical Radioisotopes Revenue by Country (2016-2026)
7.3.2 Germany Medical Radioisotopes Market Size and Forecast (2016-2026)
7.3.3 France Medical Radioisotopes Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Medical Radioisotopes Market Size and Forecast (2016-2026)
7.3.5 Russia Medical Radioisotopes Market Size and Forecast (2016-2026)
7.3.6 Italy Medical Radioisotopes Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Medical Radioisotopes Revenue by Type (2016-2026)
8.2 Asia-Pacific Medical Radioisotopes Revenue by Application (2016-2026)
8.3 Asia-Pacific Medical Radioisotopes Market Size by Region
8.3.1 Asia-Pacific Medical Radioisotopes Revenue by Region (2016-2026)
8.3.2 China Medical Radioisotopes Market Size and Forecast (2016-2026)
8.3.3 Japan Medical Radioisotopes Market Size and Forecast (2016-2026)
8.3.4 South Korea Medical Radioisotopes Market Size and Forecast (2016-2026)
8.3.5 India Medical Radioisotopes Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Medical Radioisotopes Market Size and Forecast (2016-2026)
8.3.7 Australia Medical Radioisotopes Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Medical Radioisotopes Revenue by Type (2016-2026)
9.2 South America Medical Radioisotopes Revenue by Application (2016-2026)
9.3 South America Medical Radioisotopes Market Size by Country
9.3.1 South America Medical Radioisotopes Revenue by Country (2016-2026)
9.3.2 Brazil Medical Radioisotopes Market Size and Forecast (2016-2026)
9.3.3 Argentina Medical Radioisotopes Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Medical Radioisotopes Revenue by Type (2016-2026)
10.2 Middle East & Africa Medical Radioisotopes Revenue by Application (2016-2026)
10.3 Middle East & Africa Medical Radioisotopes Market Size by Country
10.3.1 Middle East & Africa Medical Radioisotopes Revenue by Country (2016-2026)
10.3.2 Turkey Medical Radioisotopes Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Medical Radioisotopes Market Size and Forecast (2016-2026)
10.3.4 UAE Medical Radioisotopes Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Medical Radioisotopes Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Medical Radioisotopes Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Medical Radioisotopes Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Medical Radioisotopes Revenue (USD Million) by Region (2016-2021)
Table 5. Global Medical Radioisotopes Revenue Market Share by Region (2021-2026)
Table 6. NRG Corporate Information, Head Office, and Major Competitors
Table 7. NRG Major Business
Table 8. NRG Medical Radioisotopes Product and Solutions
Table 9. NRG Medical Radioisotopes Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. NTP Radioisotopes Corporate Information, Head Office, and Major Competitors
Table 11. NTP Radioisotopes Major Business
Table 12. NTP Radioisotopes Medical Radioisotopes Product and Solutions
Table 13. NTP Radioisotopes Medical Radioisotopes Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. ANSTO Corporate Information, Head Office, and Major Competitors
Table 15. ANSTO Major Business
Table 16. ANSTO Medical Radioisotopes Product and Solutions
Table 17. ANSTO Medical Radioisotopes Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. IRE Corporate Information, Head Office, and Major Competitors
Table 19. IRE Major Business
Table 20. IRE Medical Radioisotopes Product and Solutions
Table 21. IRE Medical Radioisotopes Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Nordion Corporate Information, Head Office, and Major Competitors
Table 23. Nordion Major Business
Table 24. Nordion Medical Radioisotopes Product and Solutions
Table 25. Nordion Medical Radioisotopes Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Curium Pharma Corporate Information, Head Office, and Major Competitors
Table 27. Curium Pharma Major Business
Table 28. Curium Pharma Medical Radioisotopes Product and Solutions
Table 29. Curium Pharma Medical Radioisotopes Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Eckert & Ziegler Strahlen Corporate Information, Head Office, and Major Competitors
Table 31. Eckert & Ziegler Strahlen Major Business
Table 32. Eckert & Ziegler Strahlen Medical Radioisotopes Product and Solutions
Table 33. Eckert & Ziegler Strahlen Medical Radioisotopes Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Polatom Corporate Information, Head Office, and Major Competitors
Table 35. Polatom Major Business
Table 36. Polatom Medical Radioisotopes Product and Solutions
Table 37. Polatom Medical Radioisotopes Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. China National Nuclear Corporation Corporate Information, Head Office, and Major Competitors
Table 39. China National Nuclear Corporation Major Business
Table 40. China National Nuclear Corporation Medical Radioisotopes Product and Solutions
Table 41. China National Nuclear Corporation Medical Radioisotopes Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. IDB Holland Corporate Information, Head Office, and Major Competitors
Table 43. IDB Holland Major Business
Table 44. IDB Holland Medical Radioisotopes Product and Solutions
Table 45. IDB Holland Medical Radioisotopes Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Global Medical Radioisotopes Revenue (USD Million) by Players (2019-2021)
Table 47. Global Medical Radioisotopes Revenue Share by Players (2019-2021)
Table 48. Breakdown of Medical Radioisotopes by Company Type (Tier 1, Tier 2 and Tier 3)
Table 49. Medical Radioisotopes Players Head Office, Products and Services Provided
Table 50. Medical Radioisotopes Mergers & Acquisitions in the Past Five Years
Table 51. Medical Radioisotopes New Entrants and Expansion Plans
Table 52. Global Medical Radioisotopes Revenue (USD Million) by Type (2016-2021)
Table 53. Global Medical Radioisotopes Revenue Share by Type (2016-2021)
Table 54. Global Medical Radioisotopes Revenue Forecast by Type (2021-2026)
Table 55. Global Medical Radioisotopes Revenue by Application (2016-2021)
Table 56. Global Medical Radioisotopes Revenue Forecast by Application (2021-2026)
Table 57. North America Medical Radioisotopes Revenue by Type (2016-2021) & (USD Million)
Table 58. North America Medical Radioisotopes Revenue by Type (2021-2026) & (USD Million)
Table 59. North America Medical Radioisotopes Revenue by Application (2016-2021) & (USD Million)
Table 60. North America Medical Radioisotopes Revenue by Application (2021-2026) & (USD Million)
Table 61. North America Medical Radioisotopes Revenue by Country (2016-2021) & (USD Million)
Table 62. North America Medical Radioisotopes Revenue by Country (2021-2026) & (USD Million)
Table 63. Europe Medical Radioisotopes Revenue by Type (2016-2021) & (USD Million)
Table 64. Europe Medical Radioisotopes Revenue by Type (2021-2026) & (USD Million)
Table 65. Europe Medical Radioisotopes Revenue by Application (2016-2021) & (USD Million)
Table 66. Europe Medical Radioisotopes Revenue by Application (2021-2026) & (USD Million)
Table 67. Europe Medical Radioisotopes Revenue by Country (2016-2021) & (USD Million)
Table 68. Europe Medical Radioisotopes Revenue by Country (2021-2026) & (USD Million)
Table 69. Asia-Pacific Medical Radioisotopes Revenue by Type (2016-2021) & (USD Million)
Table 70. Asia-Pacific Medical Radioisotopes Revenue by Type (2021-2026) & (USD Million)
Table 71. Asia-Pacific Medical Radioisotopes Revenue by Application (2016-2021) & (USD Million)
Table 72. Asia-Pacific Medical Radioisotopes Revenue by Application (2021-2026) & (USD Million)
Table 73. Asia-Pacific Medical Radioisotopes Revenue by Region (2016-2021) & (USD Million)
Table 74. Asia-Pacific Medical Radioisotopes Revenue by Region (2021-2026) & (USD Million)
Table 75. South America Medical Radioisotopes Revenue by Type (2016-2021) & (USD Million)
Table 76. South America Medical Radioisotopes Revenue by Type (2021-2026) & (USD Million)
Table 77. South America Medical Radioisotopes Revenue by Application (2016-2021) & (USD Million)
Table 78. South America Medical Radioisotopes Revenue by Application (2021-2026) & (USD Million)
Table 79. South America Medical Radioisotopes Revenue by Country (2016-2021) & (USD Million)
Table 80. South America Medical Radioisotopes Revenue by Country (2021-2026) & (USD Million)
Table 81. Middle East & Africa Medical Radioisotopes Revenue by Type (2016-2021) & (USD Million)
Table 82. Middle East & Africa Medical Radioisotopes Revenue by Type (2021-2026) & (USD Million)
Table 83. Middle East & Africa Medical Radioisotopes Revenue by Application (2016-2021) & (USD Million)
Table 84. Middle East & Africa Medical Radioisotopes Revenue by Application (2021-2026) & (USD Million)
Table 85. Middle East & Africa Medical Radioisotopes Revenue by Country (2016-2021) & (USD Million)
Table 86. Middle East & Africa Medical Radioisotopes Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Medical Radioisotopes Picture
Figure 2. Global Medical Radioisotopes Revenue Market Share by Type in 2020
Figure 3. Mo-99
Figure 4. Co-60
Figure 5. Lutetium 177
Figure 6. Medical Radioisotopes Revenue Market Share by Application in 2020
Figure 7. Nuclear Therapy Picture
Figure 8. Equipment Radioactive Source Picture
Figure 9. Diagnosis Picture
Figure 10. Global Medical Radioisotopes Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 11. Global Medical Radioisotopes Revenue and Forecast (2016-2026) & (USD Million)
Figure 12. Global Medical Radioisotopes Revenue Market Share by Region (2016-2026)
Figure 13. Global Medical Radioisotopes Revenue Market Share by Region in 2020
Figure 14. North America Medical Radioisotopes Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Europe Medical Radioisotopes Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Asia-Pacific Medical Radioisotopes Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. South America Medical Radioisotopes Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Middle East and Africa Medical Radioisotopes Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Medical Radioisotopes Market Drivers
Figure 20. Medical Radioisotopes Market Restraints
Figure 21. Medical Radioisotopes Market Trends
Figure 22. NRG Recent Developments and Future Plans
Figure 23. NTP Radioisotopes Recent Developments and Future Plans
Figure 24. ANSTO Recent Developments and Future Plans
Figure 25. IRE Recent Developments and Future Plans
Figure 26. Nordion Recent Developments and Future Plans
Figure 27. Curium Pharma Recent Developments and Future Plans
Figure 28. Eckert & Ziegler Strahlen Recent Developments and Future Plans
Figure 29. Polatom Recent Developments and Future Plans
Figure 30. China National Nuclear Corporation Recent Developments and Future Plans
Figure 31. IDB Holland Recent Developments and Future Plans
Figure 32. Global Medical Radioisotopes Revenue Share by Players in 2020
Figure 33. Medical Radioisotopes Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 34. Global Top 3 Players Medical Radioisotopes Revenue Market Share in 2020
Figure 35. Global Top 10 Players Medical Radioisotopes Revenue Market Share in 2020
Figure 36. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 37. Global Medical Radioisotopes Revenue Share by Type in 2020
Figure 38. Global Medical Radioisotopes Market Share Forecast by Type (2021-2026)
Figure 39. Global Medical Radioisotopes Revenue Share by Application in 2020
Figure 40. Global Medical Radioisotopes Market Share Forecast by Application (2021-2026)
Figure 41. North America Medical Radioisotopes Sales Market Share by Type (2016-2026)
Figure 42. North America Medical Radioisotopes Sales Market Share by Application (2016-2026)
Figure 43. North America Medical Radioisotopes Revenue Market Share by Country (2016-2026)
Figure 44. United States Medical Radioisotopes Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Canada Medical Radioisotopes Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Mexico Medical Radioisotopes Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Europe Medical Radioisotopes Sales Market Share by Type (2016-2026)
Figure 48. Europe Medical Radioisotopes Sales Market Share by Application (2016-2026)
Figure 49. Europe Medical Radioisotopes Revenue Market Share by Country (2016-2026)
Figure 50. Germany Medical Radioisotopes Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. France Medical Radioisotopes Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. United Kingdom Medical Radioisotopes Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Russia Medical Radioisotopes Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Italy Medical Radioisotopes Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Asia-Pacific Medical Radioisotopes Sales Market Share by Type (2016-2026)
Figure 56. Asia-Pacific Medical Radioisotopes Sales Market Share by Application (2016-2026)
Figure 57. Asia-Pacific Medical Radioisotopes Revenue Market Share by Region (2016-2026)
Figure 58. China Medical Radioisotopes Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Japan Medical Radioisotopes Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. South Korea Medical Radioisotopes Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. India Medical Radioisotopes Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Southeast Asia Medical Radioisotopes Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Australia Medical Radioisotopes Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. South America Medical Radioisotopes Sales Market Share by Type (2016-2026)
Figure 65. South America Medical Radioisotopes Sales Market Share by Application (2016-2026)
Figure 66. South America Medical Radioisotopes Revenue Market Share by Country (2016-2026)
Figure 67. Brazil Medical Radioisotopes Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Argentina Medical Radioisotopes Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Middle East and Africa Medical Radioisotopes Sales Market Share by Type (2016-2026)
Figure 70. Middle East and Africa Medical Radioisotopes Sales Market Share by Application (2016-2026)
Figure 71. Middle East and Africa Medical Radioisotopes Revenue Market Share by Country (2016-2026)
Figure 72. Turkey Medical Radioisotopes Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Saudi Arabia Medical Radioisotopes Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. UAE Medical Radioisotopes Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Methodology
Figure 76. Research Process and Data Source